Related Experiment Video
Updated: Aug 15, 2026

Isolation of Human Atrial Myocytes for Simultaneous Measurements of Ca2+ Transients and Membrane Currents
Published on: July 3, 2013
Nitrendipine block of cardiac calcium channels: high-affinity binding to the inactivated state
Abstract:
Block of Ca2+ currents by the dihydropyridine drug nitrendipine was studied in single canine ventricular cells by using the whole-cell variant of the patch clamp technique. When cells were held at depolarized membrane potentials at which Ca2+ currents were approximately equal to 70% inactivated, nitrendipine blocked Ca2+ currents very potently, with half-block by subnanomolar concentrations. The concentration dependence of block had the form expected for 1:1 binding, with an apparent dissociation constant (Kd) of 0.36 nM. In contrast, when cells were held at hyperpolarized potentials, nitrendipine blocked Ca2+ currents much less potently (Kd approximately equal to 700 nM). The results can be explained if nitrendipine binds very tightly to the inactivated state of the Ca2+ channel and only weakly to the normal resting state. The Kd estimated for binding to the inactivated state is very similar to the dissociation constants previously found for high-affinity [3H]nitrendipine binding to membrane fragments from heart, smooth muscle, brain, and other tissues; moreover, the concentration-dependent kinetics of binding to the inactivated state are similar to those reported for [3H]nitrendipine binding to membranes. These results make it seem very likely that the high-affinity [3H]nitrendipine binding site is an inactivated state of the Ca2+ channel.
Insights
Nitrendipine potently blocks calcium (Ca2+) channels in their inactivated state, not their resting state. This explains high-affinity [3H]nitrendipine binding to inactivated Ca2+ channels in cardiac cells.
Area of Science:
- Cardiovascular Physiology
- Molecular Pharmacology
- Ion Channel Biophysics
Background:
- Dihydropyridine drugs, like nitrendipine, are known to affect calcium (Ca2+) channel activity.
- Understanding the precise binding states of drugs to ion channels is crucial for pharmacology.
- Previous studies indicated high-affinity binding of [3H]nitrendipine to tissue membranes.
Purpose of the Study:
- To investigate the mechanism of calcium (Ca2+) current block by nitrendipine in canine ventricular cells.
- To determine the binding affinity of nitrendipine to different states of the Ca2+ channel.
- To correlate drug binding with known high-affinity radioligand binding sites.
Main Methods:
- Whole-cell patch clamp technique applied to single canine ventricular cells.
- Measurement of Ca2+ currents under varying membrane potentials (depolarized and hyperpolarized).
- Analysis of nitrendipine concentration-dependent block and apparent dissociation constants (Kd).
Main Results:
- Nitrendipine exhibited potent block of Ca2+ currents at depolarized potentials (70% inactivated state) with a Kd of 0.36 nM.
- Block was significantly less potent at hyperpolarized potentials (resting state) with a Kd of approximately 700 nM.
- Observed binding kinetics and affinity align with high-affinity [3H]nitrendipine binding to membrane fragments.
Conclusions:
- Nitrendipine preferentially binds to the inactivated state of the Ca2+ channel.
- The high-affinity [3H]nitrendipine binding site likely represents the inactivated state of the Ca2+ channel.
- This provides a mechanistic link between drug action and radioligand binding studies.
More Related Videos
07:42Contractions of Human-iPSC-derived Cardiomyocyte Syncytia Measured with a Ca-sensitive Fluorescent Dye in Temperature-controlled 384-well Plates
Published on: October 18, 2018
08:11Voltage-Dependent Potassium Current Recording on H9c2 Cardiomyocytes via the Whole-Cell Patch-Clamp Technique
Published on: November 11, 2022
Related Concept Videos
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Antihypertensive Drugs: Action of Calcium Channel Blockers
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...